My ePortfolio Register   

Natural defense mechanism preventing cancer at the earliest stage

A new study, published in the May issue of Nature Cell Biology, shows cells in the initial stage of cancer change their metabolism before getting eliminated by the surrounding normal cells, providing a novel target for developing cancer prevention drugs.

Most cancers begin when one or more genes in a cell mutate.

These newly "transformed" cells get extruded and eliminated after losing a competition against the surrounding normal cells in the epithelium, or the outer layer of the body.

However, the mechanism by which normal cells recognise and attack the transformed cells remains elusive.

A research team led by Professor Yasuyuki Fujita of Hokkaido University's Institute for Genetic Medicine explored this natural defence mechanism using cultured mammalian cells and a mouse model.

The study uncovered two metabolic changes occurring in the newly transformed cells: mitochondrial dysfunction and an elevated glucose uptake.

The changes were significant only when the transformed cells were surrounded by normal epithelial cells, indicating that the changes are induced by the normal cells.

Furthermore, according to the study, the metabolic changes play an important role in eliminating the transformed cells.

Interestingly, these metabolic changes are similar to the Warburg effect, which is observed in cancerous cells in the middle and latter stages of cancer.

The Warburg effect is generally thought to play tumour promoting roles whereas the newly discovered metabolic changes could suppress cancer in its initial stage. "Although these two processes have similar metabolic alterations, mitochondrial downregulation and increased glycolysis, they are governed by distinct regulators and have opposing effects on the development of cancer," says Fujita.

Their findings shed new light on the inherent ability of normal cells to eliminate cancerous cells and opens up potential avenues for cancer prevention. "Considering that the metabolic changes could either suppress or promote cancer cells depending on the stage, further elucidation of the mechanism is essential to help develop cancer prevention drugs while avoiding adverse effects," Fujita commented.

 

Source: Hokkaido University

Related news

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence